Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

INBX

Inhibrx Biosciences, Inc.

Tremor tracks 3 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • INBXInhibrx Biosciences, Inc
    10Calm

    Study of INBRX-109 in Conventional Chondrosarcoma

    Running, no new patientsPhase 2206 patientsMain results: Sep 30, 2025
  • INBXInhibrx Biosciences, Inc
    0Calm

    Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    Signing up patientsPhase 1/2340 patientsMain results: Jul 2033
  • INBXInhibrx Biosciences, Inc
    0Calm

    Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

    Signing up patientsPhase 2/3450 patientsMain results: Dec 2029

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

5 sales (5 not pre-planned) · 20 purchases

  • Lappe MarkChief Executive Officer · Oct 14, 2026Bought 2,470 sharesabout $208 thousand ·
  • Lappe MarkChief Executive Officer · Oct 14, 2026Bought 2,470 sharesabout $210 thousand ·
  • Lappe MarkChief Executive Officer · Oct 14, 2026Bought 100 sharesabout $9 thousand ·
  • Lappe MarkChief Executive Officer · Oct 14, 2026Bought 2,449 sharesabout $206 thousand ·
  • Lappe MarkChief Executive Officer · Oct 14, 2026Bought 2,451 sharesabout $208 thousand ·
  • Lappe MarkChief Executive Officer · Oct 14, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Shared information with investorsNews report (8-K)Sep 28, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 8, 2026
  • Shared quarterly resultsNews report (8-K)Aug 13, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 13, 2026
  • Signed a major agreement; Shared information with investorsNews report (8-K)Jul 16, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Bought 100 sharesabout $9 thousand ·
  • Lappe MarkChief Executive Officer · Sep 28, 2026Bought 1,500 sharesabout $148 thousand ·
  • Lappe MarkChief Executive Officer · Sep 28, 2026Bought 3,000 sharesabout $305 thousand ·
  • Lappe MarkChief Executive Officer · Sep 25, 2026Bought 3,324 sharesabout $329 thousand ·
  • Lappe MarkChief Executive Officer · Sep 25, 2026Bought 2,176 sharesabout $217 thousand ·
  • Kayyem Jon FaizBoard member · Sep 23, 2026Bought 5,000 sharesabout $500 thousand ·
  • Kayyem Jon FaizBoard member · Sep 16, 2026Bought 5,000 sharesabout $500 thousand ·
  • MANHARD KIMBERLYBoard member · Sep 15, 2026Sold 500 sharesabout $53 thousand · not pre-planned
  • MANHARD KIMBERLYBoard member · Sep 14, 2026Sold 500 sharesabout $55 thousand · not pre-planned
  • MANHARD KIMBERLYBoard member · Sep 11, 2026Sold 500 sharesabout $56 thousand · not pre-planned
  • MANHARD KIMBERLYBoard member · Sep 9, 2026Sold 500 sharesabout $58 thousand · not pre-planned
  • MANHARD KIMBERLYBoard member · Sep 8, 2026Sold 500 sharesabout $58 thousand · not pre-planned
  • Kayyem Jon FaizBoard member · Sep 8, 2026Bought 5,000 sharesabout $568 thousand ·
  • FORSYTH DOUGLASBoard member · Sep 8, 2026Bought 2,500 sharesabout $287 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 5,895 sharesabout $585 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 6,605 sharesabout $665 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 1,100 sharesabout $118 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 500 sharesabout $54 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 1,219 sharesabout $136 thousand ·
  • Lappe MarkChief Executive Officer · Sep 8, 2026Bought 9,681 sharesabout $1.1 million ·
    • Shared information with investors; Other newsNews report (8-K)
    Jun 15, 2026
  • News reportNews report (8-K)Jun 3, 2026
  • Shared quarterly resultsNews report (8-K)May 14, 2026
  • Quarterly reportQuarterly report (10-Q)May 14, 2026
  • Shared information with investors; Other newsNews report (8-K)May 11, 2026